Abstract：【Objective】To explore the relationship between bone marrow megakaryocyte number and corresponding therapeutic effect in patients with adult immune thrombocytopenia (ITP).【Methods】A total of 140 adult ITP patients treated in our hospital were selected in this study.Before treatment, all of the patients received bone marrow megakaryocyte smears. According to the number of bone marrow megakaryocyte, patients were divided into three groups: group Ⅰ<7/4.5 cm2, group Ⅱ 7~35/cm2, and group Ⅲ>35/cm2. All patients of the three groups received the same treatment, and the therapeutic effect were compared among them.【Results】The total effective rate was 25.00% (4/16) in group I, 76.47% (26/34) in group Ⅱ, and 93.33% (84/90) in group Ⅲ. The total effective rate of group Ⅲ was significantly higher than that of group Ⅰ and group Ⅱ; The rate of group Ⅱ was significantly higher than that of group Ⅰ. The difference between groups was statistically significant (P<0.01).【Conclusion】The changes in the number of bone marrow megakaryocytes in adult ITP patients have a great influence on the therapeutic effect. The increase in the number of bone marrow megakaryocytes is beneficial to improve the therapeutic effect.
许杰. 成人免疫性血小板减少症骨髓巨核细胞数变化与疗效的关系[J]. 医学临床研究, 2018, 35(3): 486-488.
XU Jie. Relationship Between Bone Marrow Megakaryocyte Number and Therapeutic Effect in Adult Immune Thrombocytopenia. JOURNAL OF CLINICAL RESEARCH, 2018, 35(3): 486-488.
[1] Tasaki T,Yamada S,Nabeshima A,et al.An autopsy case of myocardial infarction due to idiopathic thrombotic thrombocytopenic purpura[J].Diagn Pathol,2015,10(1):52. [2] Rijcken E,Mees ST,Bisping G,et al.Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP):a retrospective cohort study on longtime response predicting factors based on consensus criteria[J].Int J Surg,2014,12(12):1428-1433. [3] 中华医学会血液学分会血栓与止血学组.成人原发免疫性血小板减少症诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):975-977. [4] 朱蕾,卢兴国,赵小英,等.骨髓涂片和切片中的巨核细胞多形性改变在慢性骨髓增殖性疾病中的诊断意义[J].中华检验医学杂志,2010,33(2):143-148. [5] 马利锋,康建省,李涛,等.腹腔镜脾切除术治疗115例免疫性血小板减少症的疗效分析[J].重庆医学,2014,(10):1199-1200. [6] Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,13(11):2386-2393. [7] 陈诚,王佳,李义德,等.免疫性血小板减少症患儿外周血CD4+CD25+调节T细胞和Th17细胞的变化[J].宁夏医科大学学报,2013,35(8):864-867. [8] Musa F,Baidas S.Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis,Rituximab,Cyclophosphamide and Splenectomy[J].Case Rep Oncol,2015,8(1):196-199.
2018, Vol. 35 
